This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Stock Market Today: Parliament Shooting, Higher Oil Inventories Drive Stocks Down

Stock Market Today: Parliament Shooting, Higher Oil Inventories Drive Stocks Down

U.S. stocks move lower in midday trading on Wednesday on higher than forecast oil inventories released by the Energy Information Administration.

10/22/14 - 02:40 PM EDT

Why Biogen Idec (BIIB) Stock Is Tanking Today

  • Tickers in this article:
  • BIIB

Biogen Idec (BIIB) shares are declining after the company confirmed the death of a patient using its multiple sclerosis treatment.

10/22/14 - 12:39 PM EDT

Stock Market Today: Parliament Shooting, Higher Oil Inventories Drive Stocks Down

Stock Market Today: Parliament Shooting, Higher Oil Inventories Drive Stocks Down

U.S. stocks move lower in midday trading on Wednesday on higher than forecast oil inventories released by the Energy Information Administration.

10/22/14 - 02:40 PM EDT

How WIll Intuitive Surgical (ISRG) Stock React to Its Earnings Beat Today?

How WIll Intuitive Surgical (ISRG) Stock React to Its Earnings Beat Today?

  • Tickers in this article:
  • ISRG

Intuitive Surgical (ISRG) shares are down despite beating analysts third quarter revenue and earnings guidance.

10/22/14 - 12:07 PM EDT

Why Thermo Fisher Scientific (TMO) Stock Is Declining Today

Why Thermo Fisher Scientific (TMO) Stock Is Declining Today

  • Tickers in this article:
  • TMO

Thermo Fisher Scientific (TMO) shares are dropping after the company lowered its full year revenue and earnings guidance on Wednesday.

10/22/14 - 10:18 AM EDT

Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results

Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results

But you're getting way ahead of the facts if you think Regulus has a game-changing hepatitis C therapy in its grasp already. There's a lot more questions to be answered.

10/22/14 - 11:52 AM EDT

Why Amgen (AMGN) Stock Is Rising in Afternoon Trading Today

Why Amgen (AMGN) Stock Is Rising in Afternoon Trading Today

  • Tickers in this article:
  • AMGN

Amgen (AMGN) shares are climbing after an activist hedge fund manager Dan Loeb released a positive letter to investors.

10/21/14 - 03:19 PM EDT

Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results

Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results

My question about Achillion and ACH-3422 question sparked a robust Twitter debate, which I've reproduced below with some additional comments and explanatory notes.

10/22/14 - 08:39 AM EDT

Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear

Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear

  • Tickers in this article:
  • IBIO
  • RAI

Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.

10/21/14 - 06:10 AM EDT

Why Illumina (ILMN) Stock Is Gaining in After-Hours Trading Today

Why Illumina (ILMN) Stock Is Gaining in After-Hours Trading Today

  • Tickers in this article:
  • ILMN

Illumina (ILMN) shares are climbing in after-hours trading following its third quarter earnings beat.

10/20/14 - 05:07 PM EDT

First Detailed Look at Celgene Crohn's Disease Pill Impresses

First Detailed Look at Celgene Crohn's Disease Pill Impresses

As a pill, Celgene's GED-031 (also known as mongersen) has the potential to become a preferred Crohn's therapy over injectable drugs like Abbvie's top-selling Humira.

10/20/14 - 10:56 AM EDT

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech columnist Adam Feuerstein answers readers' questions about health care.

10/17/14 - 07:05 AM EDT

Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback

Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback

Here are four biotechs to consider, two of which are involved in developing drugs to fight the Ebola virus.

10/17/14 - 01:50 PM EDT

FDA Approves Competing Lung Disease Drugs From Roche and Boehringer

FDA Approves Competing Lung Disease Drugs From Roche and Boehringer

  • Tickers in this article:
  • RHHBY

U.S. patients suffering from idiopathic pulmonary fibrosis finally gain access to Esbriet, approved for use in Europe since early 2011.

10/15/14 - 04:07 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs